2 results
Approved WMOCompleted
Lu AF28996 is an orally administered investigational compound of a potent, long-acting dopamine agonist, Lu AA40326, currently under development by H. Lundbeck A/S for the treatment of Parkinson*s disease (PD). Primary Objective:to investigate theā¦
Approved WMOPending
Gaining insight in the potential benefit and relevance of the automatic classifier in various acoustic conditions for children using Advanced Bionics Sky CI(s).